UNC Charlotte researchers are contributing to pioneering breakthroughs in cancer therapeutics, communicable disease ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

ABC11's and DPAC Truist Broadway New York Trip Tune-in-to-Win Sweepstakes Sweepstakes ... Cary | Christine M., Durham. ABC11's Chinese Lantern Festival Tickets Giveaway. Winner will be selected ...

Tune Therapeutics, which has dual headquarters in Seattle and Durham, North Carolina, raised over $175 million in January. Seattle-based Umoja Biopharma raised $100 million the same week Tune and ...

The LIGHTHOUSE study is a Phase I/II, open-label, dose-escalation and dose-expansion clinical trial evaluating the safety and tolerability of ATSN-201 in male patients ages six and older with a ...

Gift 5 articles to anyone you choose each month when you subscribe. Biotech company Alterity Therapeutics is seeking to raise about $40 million following stellar results from a Phase 2 results ...

Viking Therapeutics showcased significant clinical progress across its pipeline in 2024, with VK2735 emerging as a key driver for future growth. The company is well-positioned for Phase 3 trials ...

India's journey from the ODI World Cup to the Champions Trophy was always meant to span nine matches. The issue isn't that it's too few; that's just how the modern game rolls. It's that only a ...

His Monday LS speech had elements of good oppn politics. It avoided shrill anti-institutional rhetoric. But can he really stop being a political insurgent & focus consistently on issues like ...